Web Research
Web Research — What the Internet Knows
The Bottom Line from the Web
The filings show a Korean semiconductor test-handler maker whose FY2025 revenue nearly doubled. The web reveals the part the filings underplay: control of Mirae Corporation flipped in July 2023 to a holding chain anchored by Nexturn Bioscience / Nexturn Roll Korea, with intermediate stakes routed through KOSDAQ-listed talent agency Studio Santa Claus Entertainment and ROA Holdings (chairman On Seong-jun, listed as the highest-paid "non-operational" executive), and that on 2026-01-04 Nexturn Roll Korea announced it would inject ₩6.499993696 billion of additional funding into Mirae. Pair that with the issuer's own disclosure that 56.5% of FY2025 revenue came from a single Chinese counterparty (YILINING / Yiling Trading) — and the bottom-line picture is a small-cap precision-equipment business riding a Chinese-memory order surge under the control of an entertainment-and-biotech holding pyramid.
The combination of (a) a control flip to a non-industrial holding chain in mid-2023, (b) a 16:1 reverse stock split (2025-06-27) followed by a planned 5:1 forward split (2026-07-27), (c) heavy convertible-bond conversions giving Nexturn Roll Korea ~32.31% via CB Series 8 and 9, and (d) a ₩6.5bn related-party equity injection in January 2026 is the dominant capital-structure narrative external coverage points to. None of these items appear in standard fundamental screens.
What Matters Most
Ten findings, ranked by how much they would change an investor's view of Mirae Corporation today.
1. Controlling shareholder is a non-industrial holding chain — and just injected more capital
On 2026-01-04 Mirae disclosed that it expects to receive ₩6,499,993,696 in funding from Nexturn Roll Korea Co., Ltd. (per Marketscreener news feed for 025560 — https://www.marketscreener.com/quote/stock/MIRAE-CORPORATION-6494937/). Control of Mirae passed from Gwangrim to Nexturn Bioscience in July 2023; specialist queries trace the chain as Nexturn Roll Korea (~32.31%, mostly via CB Series 8 and 9 conversions) → Studio Santa Claus Entertainment (KOSDAQ:204630, formerly Huayi Brothers Korea / Fleet Entertainment, ~18%) → ROA Holdings (~27%, chairman On Seong-jun / 온성준). That a loss-making entertainment-and-biotech holding pyramid is now the controlling shareholder of a 1983-vintage semiconductor-equipment maker is the single most consequential governance fact external sources surface.
Direction of capital is from the parent into the operating subsidiary, which is unusual for a holding-pyramid structure — typically money flows the other way. Combined with Nexturn's CB conversion economics, this round increases (not reduces) the related-party exposure.
2. Customer concentration is severe and geographically/politically loaded
Forensic, Warren, Industry and Historian specialist queries all flag the same fact: a single Chinese counterparty accounted for 56.5% of FY2025 revenue. The counterparty is identified in two single-supply DART contract disclosures as Yiling Trading (YILINING PRECISION), announced on the Marketscreener feed for 2025-09-08 as "Mirae Signs Two Semiconductor Inspection Equipment Supply Contracts with China's Yiling Trading." English-language sources could not establish Yilining's ultimate beneficial owner, leaving open whether the equipment is flowing downstream to a US Entity-Listed counterparty such as CXMT (added Dec 2024) or YMTC (added Dec 2022).
US BIS expansion of back-end test-equipment export controls is the most-watched 2026 rule change. If Yilining's downstream user is added to (or already on) the Entity List, more than half of FY2025 revenue is at risk of being curtailed by a single policy action.
3. Top-line surged 97.68% but margins compressed — operating leverage went the wrong way
EMIS (https://www.emis.com/php/company-profile/KR/Mirae_Corporation_en_1651085.html) summarises the FY2025 YoY change set:
Net sales almost doubled, yet EBITDA shrank −5.37% and operating-profit margin fell 16.18 percentage points. The classic interpretation — Mirae is shipping more equipment at thinner mix and worse pricing — is not contradicted by anything else in the search results.
4. Sustained DART-filed order book, but average ticket size is small
The Marketscreener news ticker (https://www.marketscreener.com/quote/stock/MIRAE-CORPORATION-6494937/) records a heavy 2025–26 cadence of single-supply contract DART filings, summarised in the timeline table further down. Total disclosed order flow across the last twelve months is in the ₩50–60 billion range, against FY2025 revenue of ₩50.78 billion — a credible forward-bookings proxy that suggests revenue momentum is not yet rolling over.
5. Lagging peer set despite the recent rally
Yahoo Finance places Mirae's market cap at ₩123.272 billion (close 2026-05-21, ₩27,600). Marketscreener's peer table shows 5-day +26.32%, 1-year +169.11%, 3-year −61.52%. The peer ATE/handler group (KLA, Advantest, Cohu, Teradyne) rallied +130–700% over the same 3-year window. The +94% one-month surge in April–May 2026 that the technicals specialist flagged is closer to peer catch-up than to a fundamental re-rating; no English source attributes a specific catalyst.
Bull case in the price action: a small-cap memory-test handler making up lost ground as Chinese DRAM/NAND capex re-accelerates. Bear case: the rally is short-covering and beta — when peer beta cools, Mirae has further to give back.
6. Equity-restructuring activity that disqualifies historical share-count comparisons
Investing.com split history (https://www.investing.com/equities/mirae-historical-data-splits) records a 16:1 reverse stock split on 2025-06-27 (0.0625-for-1) and a scheduled 5-for-1 forward split on 2026-07-27. The reverse split is the standard tell of either KOSDAQ minimum-price compliance or a clean-up after heavy CB-driven dilution. Any per-share or share-count series sourced from before 2025-06-27 must be adjusted before it can be compared to post-split data; few third-party feeds do this correctly for KOSDAQ small-caps.
7. FY2023 was a near-collapse — and the financial statements were restated
Specialist queries flag a FY2023 revenue collapse of roughly −61% and a net loss in the ₩31.5 billion range under former CEO Sun Jong-eob, coinciding with the broader memory-test downturn and with the July-2023 control flip. Forensic specialist queries (Korean-language "재무제표 정정") indicate the FY2023 financial statements were restated, but no English-source reconciliation was found. The combination of an inflection-low FY, a CEO change, a controlling-shareholder change, and a restatement in a single 12-month window is the kind of event cluster that warrants reading the Korean DART filings directly.
8. The FY2024 ₩36.26 billion PP&E spend has no disclosed counterparty in English sources
Forensic specialist query "FY2024 capex 36 billion PP&E land building facility purchase counterparty" returned no English-source identification of who Mirae bought the land/building/facility from. With control resting in a related-party holding chain, the natural follow-up question is whether the seller was an arm's-length party or another entity within the Nexturn / ROA / Studio Santa Claus pyramid.
Open evidence gap. The DART filing exists in Korean; English coverage does not surface the counterparty. Until that is resolved, the FY2024 capex spend is the second-largest related-party question after the Jan-2026 funding round.
9. No analyst coverage; no governance score; thin insider-transaction data
Investing.com, AdvFN and Yahoo all surface placeholder pages for "analyst ratings and price targets for 025560" but no actual coverage is published. ISS Governance QualityScore is N/A. Simply Wall St ownership page reads: "Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months" (https://simplywall.st/stocks/kr/semiconductors/kose-a025560/mirae-shares/ownership). For a stock that has rallied +169% over a year, the absence of any sell-side or governance-watchdog scrutiny is itself a finding — the rally is happening in a coverage vacuum.
10. Heavy noise from unrelated "Mirae" entities — most lawsuit/regulatory hits do not apply
Web searches for "Mirae" return dominant results for Mirae Asset Securities (KRX:006800), Mirae Asset Global Investments, Mirae Industry (civil-engineering, Siheung-based), Mirae IT, Mirae Eng (oil & gas) and a US 485BPOS SEC filing for a Mirae mutual fund. All flagged regulatory/litigation hits — Ryze v. Mirae Asset Securities arbitration (July 2023), PS Financial ₩200bn won fraud (Jan 2025), SEC/FINRA BrokerCheck items — belong to the financial-services group, not to Mirae Corporation 025560. A reader who relies on a name-only news scrape will be badly misled on litigation exposure.
Recent News Timeline
The cluster of high-significance items in late 2025 / early 2026 — the Yiling Trading contracts, the ₩14 bn and ₩10 bn orders, then the Nexturn funding round — is the spine of the post-control-flip recovery narrative. The cadence of small DART-filed single-supply contracts in March 2026 is the secondary tape that the market appears to be trading.
What the Specialists Asked
Thirty-three specialist questions were issued across nine specialist queues. Below: the questions, the synthesised answer, the source signal and a confidence note. Questions where English-language sources returned no primary evidence are flagged explicitly — those are the gaps the Korean-language DART filings would need to close.
Governance and People Signals
The official roster from Yahoo Finance (https://finance.yahoo.com/quote/025560.KS/profile/) and the DART entity record:
Three patterns stand out:
- ISS Governance QualityScore is N/A. No independent governance scoring exists. A reader cannot triangulate board quality through the usual screens.
- Highest-paid executive is "non-operational." Specialist queries flag On Seong-jun (chairman of ROA Holdings, up the control chain) as receiving the largest compensation despite a non-operational title. The DART executive-pay disclosure is the primary source — English coverage does not reproduce the number.
- No insider-transaction signal. Simply Wall St explicitly reports "Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months." For a stock up +169% in twelve months, the inability to verify whether insiders are taking liquidity is the relevant gap, not the absence of a flagged sale.
The Ryze v. Mirae Asset Securities arbitration (July 2023), PS Financial ₩200bn won fraud (January 2025), and various SEC/FINRA BrokerCheck items returned by name-only searches refer to Mirae Asset Securities (KRX:006800) — a separate Park Hyeon-joo group company — and do not apply to Mirae Corporation 025560.
Name-only news scrapes will systematically misattribute the Mirae Asset Securities litigation to 025560. Any investor monitoring this name should filter on ticker / KRX corp code (00197759), not on the string "Mirae".
Industry Context
The Industry tab already covers the structural primer. The external evidence that newly bears on Mirae specifically:
- Global semiconductor-equipment market is sized at USD 115–138 billion in 2025–26, growing 9–10% CAGR to USD 220–330 billion by 2031–35 per Coherent Market Insights and Mordor Intelligence — but these forecasts are dominated by front-end and lithography (ASML, Applied, Lam, KLA, Tokyo Electron). Mirae's back-end test-handler and SMT mounter segment is a much smaller slice and is not separately sized in the returned pages.
- HBM is the dominant industry catalyst through 2027 — 2 nm mass production starting late 2025, 1.6 nm starting late 2026, HBM4 ramping — but the named HBM-test winners are Hanmi Semiconductor and Techwing, not Mirae. No source ties Mirae's product roadmap to HBM known-good-die test flows. This is the largest structural risk if it remains true.
- SEAJ forecasts Japanese semiconductor equipment sales at ¥5.35 trillion in fiscal 2026 (kantenna.com). Korean small-cap equipment makers are positioned as second-tier suppliers into both Korean memory (SK Hynix, Samsung) and Chinese memory; recent disclosed orders suggest Mirae's recent revenue mix tilts more Chinese than Korean.
- US BIS back-end export-control expansion is the most-watched 2026 rule change. Back-end test equipment is largely exempt today; if controls extend, Mirae's 56.5%-of-revenue Chinese counterparty is the direct exposure.